Yasmin Aly

Dr. Yasmin Aly

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2025 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
SASahar Alizada
Sahar Alizada
YAYasmin Aly
Yasmin Aly
HBHongbo Bao
Hongbo Bao
DLDhairya A Lakhani
Dhairya A Lakhani
VYVivek Yedavalli
Vivek Yedavalli
JMJanet Mei
Janet Mei
BACKGROUND AND PURPOSE: Differentiating non-enhancing glioblastoma from vasogenic edema remains a challenge in neuroimaging. This study evaluates the utility of diffusion-weighted and dynamic susceptibility contrast MR imaging, particularly apparent diffusion coefficient (ADC) and relative cerebral blood volume (rCBV), in distinguishing these entities. MATERIALS AND METHODS: We retrospectively analyzed 111 patients diagnosed with glioblastoma with available pretreatment MRI from January 1, 2022, to December 31, 2023, including 13 patients with 15 solid non-enhancing glioblastoma lesions and 98 patients with perilesional non-enhancing T2 FLAIR hyperintensity surrounding enhancing glioblastomas. Their ADC and rCBV values were compared with those of vasogenic edema surrounding 30 brain metastatic lesions age-and sex-matched to solid non-enhancing glioblastoma lesions. Receiver operating characteristic (ROC) analysis was performed to determine optimal ADC and rCBV thresholds for classification. RESULTS: Solid non-enhancing glioblastomas exhibited significantly lower ADC values and higher rCBV values compared to vasogenic edema (1.08 ± 0.22 × 10-³ vs. 1.74 ± 0.17 × 10-³ mm2/s and 2.4 ± 0.86 vs. 0.30 ± 0.13, respectively; p < 0.001). The optimal ADC and rCBV cutoffs for differentiating solid non-enhancing glioblastoma from vasogenic edema were 1.36 × 10-³ mm2/s and 1.04, achieving excellent sensitivity (0.93-1) and specificity (1). Perilesional non-enhancing T2 FLAIR hyperintensity around enhancing glioblastomas had similar ADC values to vasogenic edema (1.67 ± 0.33 × 10-³ vs. 1.74 ± 0.17 × 10-³ mm2/s, p = 0.32) but significantly higher rCBV (0.60 ± 0.61 vs. 0.30 ± 0.13, p = 0.03). An rCBV cutoff value of 0.42 distinguished perilesional tumor infiltration from pure vasogenic edema with 86% specificity. CONCLUSIONS: Diffusion-and perfusion-weighted MR imaging, particularly ADC and rCBV measurements, provide valuable biomarkers for differentiating non-enhancing glioblastoma from vasogenic edema. The identified threshold values may enhance glioblastoma characterization, improve preoperative differentiation from metastases, and support more precise, image-guided clinical management. ABBREVIATIONS: rCBV = relative cerebral blood volume; IDH = Isocitric Dehydrogenase; KPS = Karnofsky Performance Status Scale; MGMT = O6-methylguanine-DNA methyltransferase; IQR = interquartile ranges; SD = standard deviation.

13 May 2025 in Kidney and Dialysis
Verified
Journal Article
Open access
PDF file
RMRhys Mendel
Rhys Mendel
JNJing Nie
Jing Nie
MKMaria Keller
Maria Keller
YAYasmin Aly
Yasmin Aly
HSHarneet Sandhu
Harneet Sandhu
LKLiise K Kayler
Liise K Kayler
Introduction: The feasibility of enrolling and retaining diverse kidney transplant (KT) seekers in remote studies is sparsely reported. Aims: This study examined the use of a mobile communication strategy to enroll and retain participants within a clinical trial of an automated digital intervention to promote self-learning for kidney transplant access. Materials and Methods: Adult KT-seekers were identified from an administrative database at a transplant center and recruited by email or text supplemented by verbal prompts. Multivariable logistic regression was used to explore participant- and study-level characteristics associated with enrollment and response rates. Results: Between April 2022 and June 2023, 743 patients were invited to participate, and 422 were enrolled. Enrollers were more likely to be younger (aOR 1.02; p < 0.001). Early enrollment was associated with text message invitation (OR 2.69, p ≤ 0.014). Survey completion at 1 month was similar across patient sociodemographic, clinical, and study characteristics; however, participants self-reporting Black race were underrepresented at month 6 (OR 0.55, p = 0.015) and month 12 (aOR 0.37, p = 0008), and males were underrepresented at month 12 (aOR 0.45, p = 0.028). Conclusion: Mobile communication methods are viable for enrolling diverse KT-seeking patients and collecting survey data remotely. More work is needed to learn how to best recruit older people and retain diverse groups long-term.

23 June 2026 in Journal of Clinical Interventional Radiology ISVIR
Verified
Journal Article
Open access
PDF file
MBMusa K. Bungish
Musa K. Bungish
AKAlyssa Knight
Alyssa Knight
YAYasmin Aly
Yasmin Aly
SPShajan Peter
Shajan Peter
JRJunaid Raja
Junaid Raja
Biliary atresia (BA) is a rare congenital biliary disorder treated with Kasai portoenterostomy, which preserves native liver function but often causes strictures and stones. We report two adult BA patients post-Kasai who underwent percutaneous transhepatic cholangioscopy (PTCS) for post-Kasai biliary complications including strictures, calculi, and cholangitis. PTCS enabled direct visualization, stone extraction, and stricture assessment despite altered anatomy. Targeted biliary drainage improved liver function and symptoms. PTCS appears to be a feasible, safe option for managing post-Kasai complications in adults and may delay liver transplantation.